BRAT 试验中小型破裂颅内动脉瘤的治疗结局
该研究基于 Barrow 破裂动脉瘤试验(BRAT)前瞻性入组患者,分析小型破裂动脉瘤(SRA)接受血管内弹簧圈栓塞与显微外科夹闭的结局。73 例 SRA 患者初始随机分配为栓塞组 40 例、夹闭组 33 例,最终 15 例接受栓塞、58 例接受夹闭;两组手术相关并发症与出院时、1 年及 6 年随访的神经功能结局相当。
要点
- SRA 患者从栓塞向夹闭的交叉率显著高于反向交叉(P < 0.001)。
- 最终接受栓塞与夹闭的 SRA 患者手术相关并发症发生率相似。
- 两组出院时及 1 年、6 年随访的不良结局(mRS > 2)无显著差异。
核心结论
- 在 BRAT 的 SRA 患者中,多数最终接受手术夹闭,从血管内治疗交叉至夹闭的比例较高。
- 血管内治疗在手术相关并发症和神经功能结局方面与手术夹闭相当。
研究设计与样本
- 研究为 Barrow 破裂动脉瘤试验(BRAT)的前瞻性入组患者分析。
- 共纳入 73 例小型破裂动脉瘤患者,初始随机分配为血管内弹簧圈栓塞 40 例、显微外科夹闭 33 例。
- 评估内容包括患者人口学特征、动脉瘤大小与特征、手术相关并发症及出院时、1 年和 6 年随访结局。
- 以改良 Rankin 量表(mRS)评分 > 2 定义为不良结局。
主要发现
- 初始分配至栓塞组的 40 例中 25 例交叉至夹闭,夹闭组无交叉至栓塞者(P < 0.001)。
- 最终 15 例接受栓塞、58 例接受夹闭;两组人口学特征及动脉瘤类型无显著差异(P ≥ 0.11)。
- 栓塞组平均动脉瘤直径显著大于夹闭组(3.0 ± 0.3 对 2.6 ± 0.6;P = 0.02)。
- 手术相关并发症在血管内治疗与显微外科治疗间相似(比值比 1.0,95%CI 0.1–10.0,P = 0.98)。
- 两组出院时及 1 年、6 年随访的不良结局(mRS > 2)相当(P = 0.48 与 0.73)。
关键数值与推荐
- 不良结局判定标准为改良 Rankin 量表(mRS)评分 > 2。
- 手术相关并发症比较的比值比为 1.0(95%CI 0.1–10.0),P = 0.98。
- 随访结局比较的 P 值分别为 0.48 和 0.73。
临床怎么用
- 对于小型破裂颅内动脉瘤,血管内栓塞与手术夹闭在并发症和神经功能结局上相当,可作为治疗选择参考。
- 需注意 SRA 中从血管内治疗转向手术夹闭的交叉率较高,术前应评估这种可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment of small ruptured aneurysms (SRAs) remains controversial, with literature reporting difficulty with endovascular versus microsurgical approaches. This paper analyzes outcomes after endovascular coiling and microsurgical clipping among patients with SRAs prospectively enrolled in the Barrow Ruptured Aneurysm Trial (BRAT). METHOD: All BRAT patients were included in this study. Patient demographics, aneurysm size, aneurysm characteristics, procedure-related complications, and outcomes at discharge and at 1-year and 6-year follow-up were evaluated. A modified Rankin scale (mRS) score > 2 was considered a poor outcome. RESULTS: Of 73 patients with SRAs, 40 were initially randomly assigned to endovascular coiling and 33 to microsurgical clipping. The rate of treatment crossover was significantly different between coiling and clipping; 25 patients who were assigned to coiling crossed over to clipping, and no clipping patients crossed over to coiling (P < 0.001). Among SRA patients, 15 underwent coiling and 58 underwent clipping; groups did not differ significantly in demographic characteristics or aneurysm type (P ≥ 0.11). Mean aneurysm diameter was significantly greater in the endovascular group (3.0 ± 0.3 vs 2.6 ± 0.6; P = 0.02). The incidence of procedure-related complications was similar for endovascular and microsurgical treatments (odds ratio [95% confidence interval], 1.0 [0.1-10.0], P = 0.98). Both groups had comparable overall outcome (mRS score > 2) at discharge and 1-year and 6-year follow-up (P = 0.48 and 0.73, respectively). CONCLUSIONS: Most SRA patients in the BRAT underwent surgical clipping, with a high rate of crossover from endovascular approaches. Endovascular treatment was equivalent to surgical clipping with regard to procedure-related complications and neurologic outcomes.
引用
- Catapano JS, Nguyen CL, Frisoli FA, et al. Small intracranial aneurysms in the Barrow Ruptured Aneurysm Trial (BRAT). Acta Neurochir (Wien). 2020. PMID: 33034770. doi:10.1007/s00701-020-04602-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。